Home
Conditions
Lymphoma, Mantle-Cell

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

NCT04323657

Conditions: Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +20 more
Locations: Colorado Blood Cancer Institute Denver, Colorado, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

NCT00644189

Conditions: Anaplastic Large-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Chronic Disease, +35 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma

NCT03019640

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma

NCT03836768

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Peking University Cancer Hospital Beijing, China

View Trial Details

Completed

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

NCT00002663

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +44 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma

NCT02257242

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: Rhode Island Hospital and The Miriam Hospital Providence, Rhode Island, United States

View Trial Details

Completed

Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma

NCT00005780

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT

NCT04629430

Conditions: Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, +42 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma

NCT04918940

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Centre Henri Becquerel Rouen, France

View Trial Details

Completed

A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma

NCT03877055

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Commack Commack, New York, United States

Memorial Sloan Kettering Westchester Harrison, New York, United States

View Trial Details

Lymphoma, Mantle-Cell

Lymphoma, Mantle-Cell trial results

Related conditions